Literature DB >> 15361976

Synergistic action of praziquantel and host specific immune response against Schistosoma mansoni at different phases of infection.

Fabio Ribeiro1, Rômulo Teixeira de Mello, Carlos Alberto Pereira Tavares, John Robert Kusel, Paulo Marcos Zech Coelho.   

Abstract

The interaction between specific immune response to Schistosoma mansoni and praziquantel (PZQ) was studied in mice. In mice harboring concomitant immunity, 6-day-old parasites treated with PZQ were more effectively removed than 24 h treated parasites despite both had a significant worm burden reduction when compared with respective treated controls. These results show that PZQ can be effective at the skin and lung stages of parasite's development mainly acting with a established specific immune response, and particularly at the lung phase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361976     DOI: 10.1590/s0036-46652004000400010

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  8 in total

1.  Antibody response in mice infected with Mesocestoides vogae (syn. Mesocestoides corti) tetrathyridia after treatment with praziquantel and liposomised glucan.

Authors:  Gabriela Hrckova; Samuel Velebný; Grigorij Kogan
Journal:  Parasitol Res       Date:  2007-01-25       Impact factor: 2.289

2.  Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells.

Authors:  Jinfeng Liu; Delong Kong; Jingfan Qiu; Yanci Xie; Zhongkui Lu; Chunlei Zhou; Xinjian Liu; Rong Zhang; Yong Wang
Journal:  Br J Pharmacol       Date:  2019-12-29       Impact factor: 8.739

3.  Imaging schistosomes in vivo.

Authors:  Greice Krautz-Peterson; David Ndegwa; Kristine Vasquez; Houari Korideck; Jun Zhang; Jeffrey D Peterson; Patrick J Skelly
Journal:  FASEB J       Date:  2009-04-03       Impact factor: 5.191

4.  Efficacy of injectable praziquantel for elimination of trematode metacercariae in bluegills (Lepomis macrochirus) and quantification of parasite death by propidium iodide staining.

Authors:  Chris Bader; Jeba Jesudoss Chelladurai; David E Starling; Douglas E Jones; Matthew T Brewer
Journal:  Parasitol Res       Date:  2017-12-20       Impact factor: 2.289

Review 5.  Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Amel el-Sahn; Azza Hassan
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

6.  Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.

Authors:  Marwa H El-Faham; Maha M Eissa; Joseph E Igetei; Eglal I Amer; Susan Liddell; Mervat Z El-Azzouni; Michael J Doenhoff
Journal:  PLoS Negl Trop Dis       Date:  2017-08-25

7.  Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection.

Authors:  Ulrich Membe Femoe; Hermine Boukeng Jatsa; Valentin Greigert; Julie Brunet; Catherine Cannet; Mérimé Christian Kenfack; Nestor Gipwe Feussom; Joseph Bertin Kadji Fassi; Emilenne Tienga Nkondo; Ahmed Abou-Bacar; Alexander Wilhelm Pfaff; Théophile Dimo; Pierre Kamtchouing; Louis-Albert Tchuem Tchuenté
Journal:  PLoS Negl Trop Dis       Date:  2022-04-21

8.  Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII.

Authors:  Hong You; Donald P McManus; Wei Hu; Michael J Smout; Paul J Brindley; Geoffrey N Gobert
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.